Waldmann TA - Search Results

1

Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.

Berkowitz JL, Janik JE, Stewart DM, Jaffe ES, Stetler-Stevenson M, Shih JH, Fleisher TA, Turner M, Urquhart NE, Wharfe GH, Figg WD, Peer CJ, Goldman CK, Waldmann TA, Morris JC. Berkowitz JL, et al. Among authors: waldmann ta. Clin Immunol. 2014 Dec;155(2):176-87. doi: 10.1016/j.clim.2014.09.012. Epub 2014 Sep 28. Clin Immunol. 2014. PMID: 25267440 Free PMC article. Clinical Trial.

2

Prolongation of graft survival in primate allograft transplantation by yttrium-90-labeled anti-Tac in conjunction with granulocyte colony-stimulating factor.

Parenteau GL, Dirbas FM, Garmestani K, Brechbiel MW, Bukowski MA, Goldman CK, Clark R, Gansow OA, Waldmann TA. Parenteau GL, et al. Among authors: waldmann ta. Transplantation. 1992 Dec;54(6):963-8. doi: 10.1097/00007890-199212000-00004. Transplantation. 1992. PMID: 1281566

3

The interleukin-2 receptor: a target for immunotherapy.

Waldmann TA, Goldman C, Top L, Grant A, Burton J, Bamford R, Roessler E, Horak I, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Adv Exp Med Biol. 1992;323:57-66. doi: 10.1007/978-1-4615-3396-2_8. Adv Exp Med Biol. 1992. PMID: 1485565 Review. No abstract available.

4

Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection.

Waldmann TA. Waldmann TA. Annu Rev Immunol. 1992;10:675-704. doi: 10.1146/annurev.iy.10.040192.003331. Annu Rev Immunol. 1992. PMID: 1590999 Review.

5

Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor.

Burton J, Goldman CK, Rao P, Moos M, Waldmann TA. Burton J, et al. Among authors: waldmann ta. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7329-33. doi: 10.1073/pnas.87.18.7329. Proc Natl Acad Sci U S A. 1990. PMID: 1976256 Free PMC article.

6

Lymphokine receptor-directed therapy: a model of immune intervention.

Waldmann TA, Grant A, Tendler C, Greenberg S, Goldman C, Bamford R, Junghans RP, Nelson D. Waldmann TA, et al. J Clin Immunol. 1990 Nov;10(6 Suppl):19S-28S; discussion 28S-29S. doi: 10.1007/BF00918688. J Clin Immunol. 1990. PMID: 2081786 Review.

7

Selective elimination in vitro of alloresponsive T cells to human transplantation antigens by toxin or radionuclide conjugated anti-IL-2 receptor (Tac) monoclonal antibody.

Kozak RW, Fitzgerald DP, Atcher RW, Goldman CK, Nelson DL, Gansow OA, Pastan I, Waldmann TA. Kozak RW, et al. Among authors: waldmann ta. J Immunol. 1990 May 1;144(9):3417-23. J Immunol. 1990. PMID: 2139454

8

Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features.

Wright JJ, Wagner DK, Blaese RM, Hagengruber C, Waldmann TA, Fleisher TA. Wright JJ, et al. Among authors: waldmann ta. Blood. 1990 Nov 15;76(10):2046-51. Blood. 1990. PMID: 2146980 Free article.

9

The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.

Kreitman RJ, Chaudhary VK, Waldmann T, Willingham MC, FitzGerald DJ, Pastan I. Kreitman RJ, et al. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8291-5. doi: 10.1073/pnas.87.21.8291. Proc Natl Acad Sci U S A. 1990. PMID: 2236041 Free PMC article.

10

Use of yttrium-90-labeled anti-Tac antibody in primate xenograft transplantation.

Cooper MM, Robbins RC, Goldman CK, Mirzadeh S, Brechbiel MW, Stone CD, Gansow OA, Clark RE, Waldmann TA. Cooper MM, et al. Among authors: waldmann ta. Transplantation. 1990 Nov;50(5):760-5. doi: 10.1097/00007890-199011000-00005. Transplantation. 1990. PMID: 2238051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

654 results

Search Page